First Time Loading...

Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 82.44 USD -1.62% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one BMRN stock under the Base Case scenario is 89.19 USD. Compared to the current market price of 82.44 USD, Biomarin Pharmaceutical Inc is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BMRN Relative Value
Base Case
89.19 USD
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.3
P/S
P/S
Price to Sales
6.3
vs History
96
vs Industry
60
Median 3Y
7.8
Median 5Y
8.1
Industry
8.3
Forward
5.6
More Details
76.2
P/E
P/E
Price to Earnings
76.2
vs History
53
vs Industry
2
Median 3Y
136.2
Median 5Y
99.8
Industry
26.8
Forward
48.7
More Details
55.8
P/OCF
P/OCF
Price to OCF
55.8
vs History
85
vs Industry
3
Median 3Y
101.2
Median 5Y
109.6
Industry
23.3
More Details
96.6
P/FCFE
P/FCFE
Price to FCFE
96.6
vs History
38
vs Industry
2
Median 3Y
416.3
Median 5Y
49.2
Industry
21.4
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
95
vs Industry
31
Median 3Y
3.5
Median 5Y
3.6
Industry
2.6
More Details
6.1
EV/S
EV/S
Enterprise Value to Sales
6.1
vs History
96
vs Industry
50
Median 3Y
7.8
Median 5Y
8
Industry
7.5
Forward
5.4
More Details
7.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.8
vs History
96
vs Industry
47
Median 3Y
10.4
Median 5Y
10.8
Industry
9.2
More Details
53.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
53.8
vs History
73
vs Industry
2
Median 3Y
114.5
Median 5Y
114.5
Industry
4.5
Forward
29.5
More Details
85.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
85.7
vs History
30
vs Industry
1
Median 3Y
87.2
Median 5Y
-122
Industry
4.4
Forward
36.7
More Details
54.2
EV/OCF
EV/OCF
Enterprise Value to OCF
54.2
vs History
87
vs Industry
3
Median 3Y
100.7
Median 5Y
108.4
Industry
5.6
More Details
93.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
93.1
vs History
42
vs Industry
2
Median 3Y
314.7
Median 5Y
90.6
Industry
3.4
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
90
vs Industry
43
Median 3Y
3.3
Median 5Y
3.3
Industry
5
More Details

Multiples Across Competitors

BMRN Competitors Multiples
Biomarin Pharmaceutical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
15.6B USD 6.3 76.2 53.8 85.7
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
BMRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BMRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BMRN stock valuation using valuation multiples.
Wall Street Estimates
BMRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BMRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.